NCT05698992Recruiting
Rehabilitation and Recovery for Persons With Esophageal or Gastric Cancer
Rehabilitation and Recovery for Persons With Esophageal or Gastric Cancer - a Clinical Trial Evaluating and Implementing a Model for Evidence-based Cancer Rehabilitation
Source: ClinicalTrials.gov · Last updated 15 May 2026
Brief summary (registry, in English)
This study aims to develop and evaluate a model for systematic and evidence-based cancer rehabilitation for people with esophageal and gastric cancer to provide conditions for a better quality of life and fewer cancer-related symptoms.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 2 Dec 2022
- Start date
- 27 Feb 2023
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- Region Skane
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT05698992
What you commit to
- Study type: Observational
- Planned participants: 100
- From 27 Feb 2023 to the primary completion date, 31 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- suffering from a cognitive impairment that poses a barrier for participating in the study.
Other
- unable to communicate in the Swedish language
Who the study is looking for
- over 18 years of age
- esophageal or gastric cancer
- living in Southern Sweden (Skåne)
- are planned to undergo curative surgerytreatment at Skåne University Hospital.
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Skåne University Hospital Coordinator of this site? Confirm its status | Lund | Sweden | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.